AFT’s maxigesic hits no.1 in Aus painkiller market

Company News

by Anna Napoli

AFT Pharmaceuticals (ASX:AFP) has announced its codeine-free painkiller Maxigesic is now the largest selling paracetamol-ibprofen combination painkiller in Australian pharmacies.

The rise in sales comes off the back of the Therapeutic Goods Administration's (TGA) decision to make codeine-based painkillers prescription-only.

Weekly sales data from IRi Australia for February shows Maxigesic is now ahead of all other brands in it's category sold at Australian pharmacies.

The company says sales of Maxigesic have roughly doubled since the beginning of the year.

Shares in AFT (ASX:AFP) Last traded at $2.24 on February 21 2018.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.